Guido Reifenberger

Duesseldorf, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 250 publications

Loss of MSH6 or MSH2 sensitizes progressive glioblastoma to radiotherapy.

Loss of MSH6 or MSH2 sensitizes progressive glioblastoma to radiotherapy.

Journal: The Journal of clinical investigation
Published: August 25, 2026

Age-associated epigenomic heterogeneity in papillary tumors of the pineal region: a multicenter YoungNOA investigation.

Age-associated epigenomic heterogeneity in papillary tumors of the pineal region: a multicenter YoungNOA investigation.

Journal: Acta neuropathologica communications
Published: June 02, 2026

Neurocognitive functioning in long-term survivors of glioblastoma, IDH-wildtype and astrocytoma, IDH-mutant, CNS WHO grade 4: A report from EORTC 1419 (ETERNITY).

Neurocognitive functioning in long-term survivors of glioblastoma, IDH-wildtype and astrocytoma, IDH-mutant, CNS WHO grade 4: A report from EORTC 1419 (ETERNITY).

Journal: European journal of cancer (Oxford, England : 1990)
Published: May 30, 2026

cIMPACT-NOW Update 12: Refining pathology-based risk stratification and grading for IDH-mutant gliomas.

cIMPACT-NOW Update 12: Refining pathology-based risk stratification and grading for IDH-mutant gliomas.

Journal: Neuro-oncology
Published: February 25, 2026

Detection of structural DNA variants in medulloblastomas using optical genome mapping.

Detection of structural DNA variants in medulloblastomas using optical genome mapping.

Journal: Acta neuropathologica communications
Published: November 11, 2025

Publisher Correction: Functional synapses between neurons and small cell lung cancer.

Publisher Correction: Functional synapses between neurons and small cell lung cancer.

Journal: Nature
Published: September 19, 2025

Berzosertib enhances the sensitivity of pediatric diffuse midline glioma H3K27-altered cells to radiotherapy.

Berzosertib enhances the sensitivity of pediatric diffuse midline glioma H3K27-altered cells to radiotherapy.

Journal: Cell death & disease
Published: September 01, 2025

Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas.

Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas.

Journal: Acta neuropathologica
Published: August 26, 2025

Germline variants in ATM, BRCA2, other cancer predisposition and novel candidate genes are implicated in glioma risk in adult glioma patients with a familial or personal history of tumors.

Germline variants in ATM, BRCA2, other cancer predisposition and novel candidate genes are implicated in glioma risk in adult glioma patients with a familial or personal history of tumors.

Journal: Acta neuropathologica
Published: August 26, 2025

Molecular, histologic, and clinical characterization of methylation class pleomorphic xanthoastrocytoma: An analysis of 469 tumors.

Molecular, histologic, and clinical characterization of methylation class pleomorphic xanthoastrocytoma: An analysis of 469 tumors.

Journal: Neuro-oncology advances
Published: July 30, 2025

Anatomic Staging of H3 G34-Mutant Diffuse Hemispheric Glioma.

Anatomic Staging of H3 G34-Mutant Diffuse Hemispheric Glioma.

Journal: Neurology
Published: July 10, 2025

Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries.

Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries.

Journal: Neuro-oncology
Published: June 24, 2025
Showing 1-12 of 250

Last Updated: 09/26/2026